Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × selinexor × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 42 Leukemia, Myeloid, Acute 21 Recurrence 19 Lymphoma, Large B-Cell, Diffuse 10 Sarcoma 8 Neoplasms, Plasma Cell 5 Lymphoma 5 Glioblastoma 5 Neurofibrosarcoma 4 Neoplasms 4 Neoplasm Metastasis 4 Lymphoma, T-Cell, Peripheral 4 Lymphoma, Non-Hodgkin 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Myelodysplastic Syndromes 3 Melanoma 3 Lymphoma, B-Cell 3 Liposarcoma 3 Glioma 3 Carcinoma 3 Waldenstrom Macroglobulinemia 2 Thymoma 2 Sarcoma, Alveolar Soft Part 2 Rhabdoid Tumor 2 Primary Myelofibrosis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2

Interventions

Standard of Care 7 Surveys and Questionnaires 6 COVID-19 Vaccines 6 Blood Specimen Collection 6 Specimen Handling 5 BNT162 Vaccine 5 2019-nCoV Vaccine mRNA-1273 4 Surgical Procedures, Operative 3 Practice Guidelines as Topic 3 Hydroxychloroquine 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1 ciclesonide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04534725 2023-08-24

C-SMART

Peter MacCallum Cancer Centre, Australia

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡